Stanford University
Showing 6,061-6,080 of 7,777 Results
-
Michael Saunders
Professor (Research) of Management Science and Engineering, Emeritus
BioSaunders develops mathematical methods for solving large-scale constrained optimization problems and large systems of equations. He also implements such methods as general-purpose software to allow their use in many areas of engineering, science, and business. He is co-developer of the large-scale optimizers MINOS, SNOPT, SQOPT, PDCO, the dense QP and NLP solvers LSSOL, QPOPT, NPSOL, and the linear equation solvers SYMMLQ, MINRES, MINRES-QLP, LSQR, LSMR, LSLQ, LNLQ, LSRN, LUSOL.
-
Vidushi Savant
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Savant specializes in the treatment of comorbid psychiatric disorders in medically ill patients.
She is a double board certified in Psychosomatic Medicine and General Psychiatry. -
Kim Savelson
Advanced Lecturer
Current Research and Scholarly InterestsSPECIALIZATION: Design Thinking for Writing & Research; Science and Health Communication; Storytelling; Creativity Studies; Innovation Across the Disciplines
-
Sam Sax
Lecturer
BioSam Sax is a writer, performer, and educator currently serving as an ITALIC Lecturer at Stanford University. They're the author of Yr Dead (a novel), Long listed for the National Book Award, and Pig named one of the best books of 2023 by New York Magazine and Electric Lit. They're also the author of Madness, winner of The National Poetry Series and ‘Bury It’ winner of the James Laughlin Award from the Academy of American Poets. They're the two time Bay Area Grand Slam Champion with poems published in The New York Times, Poetry Magazine, Granta and elsewhere. Sam's received fellowships from The National Endowment for the Arts, MacDowell, The Poetry Foundation, and a Wallace Stegner Fellowship from Stanford University.
-
Parnika Prashasti Saxena
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.
-
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed’s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.
Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology. -
Michael Scahill
Clinical Assistant Professor, Pediatrics - Neonatology
BioOn a trip to Mozambique while in med school here at Stanford, Dr Scahill saw the power of market interventions to transform healthcare. This led to his current focus on technology, data & AI. A veteran data scientist, his research trawls the oceans of data each patient generates for patterns to predict dangerous outcomes before they happen in Stanford's top level NICU, where he also still serves as a frontline clinician. Outside Stanford, he is the digital lead at Valley Children's hospital and advises health technology startups in Silicon Valley and beyond.
-
John Scandling
Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsTolerance induction in clinical kidney transplantation
-
Laura Schaefer
Assistant Professor of Earth and Planetary Sciences and, by courtesy, of Geophysics
Current Research and Scholarly Interestsearly Earth atmosphere; planetary differentiation; rocky exoplanet atmospheric chemistry; planetary interiors; atmosphere-interior exchange on Earth-like planets; planetary habitability; Venus atmospheric evolution; volcanic gases on Io and volatile loss
-
Lidia Schapira
Professor of Medicine (Oncology)
BioDr. Schapira is a medical oncologist with clinical expertise in the treatment of breast cancer. As the inaugural Director of Stanford's Cancer Survivorship Program, she has developed a thriving research and clinical program focused on optimizing health outcomes for people living with and beyond cancer. Dr. Schapira is interested in training future generations of physician-scientists as well as the broader community of practicing physicians through the design of innovative educational programs. Dr. Schapira's advocacy for people with cancer led to her appointment as Editor-in-Chief of the American Society of Clinical Oncology's website for the public,Cancer.Net, a position she held from 2015 until-2021. She served on the Board of Directors of the American Psychosocial Oncology Society and as Chair of the Psychosocial Interest Group of the Multinational Society for Supportive Care in Cancer. Dr. Schapira is particularily committed to reducing inequities in cancer outcomes and improve access to cancer care and cancer clinical trials. Dr. Schapira has published numerous manuscripts, lectures both nationally and internationally on issues of cancer survivorship and served as Associate Editor of the narrative section, Art of Oncology, for the Journal of Clinical Oncology from 2013 until 2023.
